Sign in
4

Changes in Ownership

ImmunityBio, Inc. Filed Acc 0001209191-21-055786

Chief Financial Officer acquired 7,598 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Sachs David C. Chief Financial Officer 2021-09-09 Option exercise +7,598 26,458 D
Derivatives
Sachs David C. Chief Financial Officer 2021-09-09 Option exercise · Restricted Stock Units −7,598 161,633 D
Loading xslF345X03/doc4.xml…